PI3K/mTOR inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PI3K/mTOR inhibitors, covering 2018-10-29 to 2018-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer [Phase 1]